Introduction
without adequate biopsy specimen for routine histological amyloidosis (AMY ), diffuse crescentic glomeruloexamination, immunofluorescence staining, or electron-nephritis (DCG), diabetic glomerulonephropathy microscope evaluation were excluded. Routine immunofluo-(DMG), fibrillary glomerulonephritis (FGP), focal rescence staining was performed using FITC-conjugated segmental glomerulosclerosis ( FSG) The specificity of antibody for immunofluorescence staining purpura (SHP), transplant glomerulopathy ( TGP).
for a 2 M was confirmed with Western blot analysis using The number and staining intensity of positive cases are normal human serum (1520 dilution) and purified human listed in Table 1 showing positive immunofluorescence staining of a 2 M in MCN and IGM had higher positive rate (25.9 and glomeruli had renal biopsy tissue embedded in Unicryl resin. 30%, Table 1 ) and intensity ( Figure 1C ) compared The thin sections were cut from these blocks and collected with FSG (10%, Table 1 ( Table 1 ) and the immunoelectron-microscopy was confirmed with Western positive cases had incomplete peripheral capillary blot analysis using normal human serum (1520 dilution) and staining with low to moderate intensity ( Figure 1A ). DCG  DMG  FGP  FSG  IGA  IGM  LPG  MCN  MGN  MPN  SHP  TGP   Total  4  6  16  3  20  20  20  17  27  42  2  3  8  tr column scattered distribution of serum a 2 M by glomerular disease is displayed in Figure 3 . The mean serum level of pooled patients in all 12 groups ( 3159 ±120 mg/L, n=115) was significant higher than that of healthy subjects ( 2040±63 mg/L, n=14, Student t test P<0.001). The mean serum levels of individual groups were also numerically higher than that of healthy control group (Figure 3 ) . Statistical analysis further revealed significant elevation of serum a 2 M in AMY, DMG, FSG, IGA, IGM, LPG, MCN, and MGN (Student t test P<0.05). The elevation of serum levels in DCG and TGP showed no statistical significance (student t test P=0.07 and 0.09 respectively). The small sample in MPG and SHP made the statistic analysis invalid. No serum sample of FGP was collected.
Discussion
In our survey of 188 cases of glomerular disease, the immunofluorescence data for a 2 M deposition showed variation of positive rate and staining pattern in different groups of glomerular disease. The total positive rate was about 20%. Patients with minimal-change nephrotic syndrome and IgM nephropathy not only had the highest mean serum a 2 M concentration but also exhibited higher frequency of glomerular deposition of a 2 M (25.9 and 30% respectively), suggesting that a 2 M should play a significant role in the pathophysiology of the diseases related to minimal-change nephrotic syndrome. The elevated circulating a 2 M levels noted in our study encompass not only glomer- 
